USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein
- 18 October 2023
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 218, 115864
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous diseaseNature Reviews Clinical Oncology, 2016
- A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cellsCell Cycle, 2015
- TRIB2 inhibits Wnt/β‐Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β‐TrCP, COP1 and Smurf1, in liver cancer cellsFEBS Letters, 2014
- USP10 Antagonizes c-Myc Transcriptional Activation through SIRT6 Stabilization to Suppress Tumor FormationCell Reports, 2013
- ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumoursBiochemical Journal, 2013
- Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblastsBone, 2013
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53Cell, 2010
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- A Genomic and Functional Inventory of Deubiquitinating EnzymesCell, 2005